Related Experiment Video
Updated: Jun 18, 2026
10:36
Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
Estrogen receptor β ligands: recent advances and biomedical applications
Filippo Minutolo1, Marco Macchia, Benita S Katzenellenbogen
1Dipartimento di Scienze Farmaceutiche, Università di Pisa, Italy. minutolo@farm.unipi.it
Medicinal Research Reviews
|December 8, 2009
Summary
Researchers have developed novel selective estrogen receptor beta (ERβ) agonists, offering potential treatments for various diseases. These compounds are crucial tools for understanding ERβ biology and its therapeutic applications.
Area of Science:
- Pharmacology
- Endocrinology
- Medicinal Chemistry
Background:
- Estrogen receptor beta (ERβ) is a key regulator of physiological functions.
- ERβ is a potential therapeutic target for cancers, endometriosis, inflammatory diseases, and cardiovascular/CNS conditions.
- Developing selective ERβ ligands is challenging due to structural similarity with ERα.
Purpose of the Study:
- To review recently developed selective ERβ ligands.
- To classify these ligands based on structure and activity.
- To highlight common pharmacophore elements and discuss therapeutic potential.
Main Methods:
- Literature review of selective ERβ ligands.
- Classification of ligands by chemical structure and biological activity.
- Analysis of pharmacophore elements for ERβ selectivity.
Main Results:
- Significant advances have been made in developing nonsteroidal and steroidal ERβ-selective agonists.
- These ligands serve as valuable tools for biological research.
- Several compounds show considerable therapeutic potential.
Conclusions:
- Selective ERβ ligands are advancing therapeutic strategies for diverse pathologies.
- Understanding pharmacophore elements is key to designing potent and selective ERβ modulators.
- Further research into these agents could unlock new biomedical applications.
Related Concept Videos
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:31Transducer Mechanism: Nuclear Receptors
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:26Signal Transduction: Overview
Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Typically, signal transduction involves three...
01:15G Protein-coupled Receptors
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...